$BMSN News 10-Q: BIO-MATRIX SCIENTIFIC

$BMSN News 10-Q: BIO-MATRIX SCIENTIFIC GROUP, INC. 7:10

New Post Public Reply Private Reply Replies (0) Message Board

Mar 14, 2014 at 1:30 PM

$BMSN News

10-Q: BIO-MATRIX SCIENTIFIC GROUP, INC. 7:10 p.m. Feb. 6, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-K: BIO-MATRIX SCIENTIFIC GROUP, INC. 3:51 p.m. Jan. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-Q: BIO-MATRIX SCIENTIFIC GROUP, INC. 12:52 p.m. Aug. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-K/A: BIO-MATRIX SCIENTIFIC GROUP, INC. 2:00 p.m. July 31, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-K/A: BIO-MATRIX SCIENTIFIC GROUP, INC. 11:02 a.m. June 21, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-Q/A: BIO-MATRIX SCIENTIFIC GROUP, INC. 10:49 a.m. June 21, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-Q/A: BIO-MATRIX SCIENTIFIC GROUP, INC. 10:42 a.m. June 21, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-Q: BIO-MATRIX SCIENTIFIC GROUP, INC. 1:07 p.m. May 17, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-Q: BIO-MATRIX SCIENTIFIC GROUP, INC. 1:01 p.m. March 21, 2013 - Edgar Online - (EDG = 10Q, 10K)

Bio-Matrix Scientific Group Inc. Announces Dividend Record Date to Receive Shares in Its Subsidiary Regen BioPharma, Inc. 3:54 p.m. March 6, 2014 - Marketwire
Regen BioPharma Announces HemaXellerate I(TM) Efficacy Data in Animal Model of Aplastic Anemia 10:35 a.m. Dec. 11, 2013 - Marketwire
Bio-Matrix Scientific Group's Regen BioPharma Retains Cook General Biotechnology for Contract Manufacturing of HemaXellerate I 11:36 a.m. Oct. 31, 2013 - Marketwire
New In-Depth Stock Reports on BMSN, CERP, NAMG and NVIV 1:03 a.m. Oct. 25, 2013 - ACCESSWIRE
Bio-Matrix Scientific Group Inc. Announces 20 Million Share Regen BioPharma Dividend to Be Paid to Shareholders 3:12 p.m. Oct. 9, 2013 - Marketwire
Bio-Matrix Scientific Group's Subsidiary Regen BioPharma Enters Into Preclinical Trials Agreement for HemaXellerate I Covering Aplastic Anemia 8:01 a.m. Sept. 26, 2013 - Marketwire
Bio-Matrix Scientific Group's Subsidiary, Regen BioPharma Announces dCellVax Breast Cancer Immunotherapeutic Product 8:31 a.m. Sept. 25, 2013 - Marketwire
Bio-Matrix Scientific Group Recruits RNA Interference Pioneer Dr. David Suhy to Regen BioPharma Inc.'s Scientific Advisor Board 10:07 a.m. Sept. 17, 2013 - Marketwire
Bio-Matrix Scientific Group Discusses Regen BioPharma's Cancer Immunotherapy Program 1:49 p.m. Aug. 16, 2013 - Marketwire
Regen BioPharma Inc. Licenses Cancer Gene Silencing Technology From Benitec BioPharma 9:48 a.m. Aug. 8, 2013 - Marketwire
Bio-Matrix Scientific Group Provides Update on Its Regen BioPharma's HemaXellerate I(TM) Clinical Program 2:37 p.m. July 31, 2013 - Marketwire
Bio-Matrix Scientific Group's Regen BioPharma Submits Response to FDA Questions Regarding HemaXellerate Clinical Program 8:30 a.m. June 7, 2013 - Marketwire
Bio-Matrix Scientific Group's Regen BioPharma Acquires Cancer Vaccine Technology With Initial Focus on Breast Cancer 8:31 a.m. May 6, 2013 - Marketwire
Bio Matrix Scientific Group & IceWEB Inc Trend Review: (OTCQB: BMSN), (OTCQB: IWEB) 1:26 p.m. April 5, 2013 - ACCESSWIRE-TNW
Bio-Matrix Scientific Group's Regen BioPharma Provides Update on Preclinical and Clinical Development 4:10 p.m. April 4, 2013 - Marketwire
Regen BioPharma Receives IND # From FDA for HemaXellerate 9:58 a.m. March 18, 2013 - Marketwire

Newer

Older

Top 5 Most Recently Viewed Articles

Match Group's Stock Outlook Remains Positive Ahead of Analyst Day

Match Group's Strong Buy Rating from Analysts Recently, Deutsche Bank reaffirmed a Buy rating for Match Group (NASDAQ: MTCH) with a consistent price target of $45.00. Their assessment reveals a cautiously optimistic approach toward Tinder’s revenue figures, having adjusted estimates marginally lower by about 1%, placing anticipated revenue for the third quarter at $505...

Myant Revolutionizes Disease Prevention at Arab Health Event

Revolutionizing Healthcare Through Innovation At Arab Health 2025, Myant, a leader in healthcare innovation, is set to present its cutting-edge mission aimed at enabling human-centric, precise, and preventive care. This revolutionary vision is made possible through the integration of artificial intelligence and their unique approach to Textile Computing™, a breakthrough...

Florida Politicians Clash Over Cannabis Legalization Efforts

Florida's Cannabis Legalization Debate Intensifies The discussion about cannabis legalization in Florida has recently escalated, putting considerable pressure on local Republican leaders. Governor Ron DeSantis has shown frustration with members of his own party, calling for them to take a firmer stand against the cannabis legalization initiative known as Amendment 3. This...

Tegna's Stock Surges Amid Nexstar Acquisition Talks

Tegna's Exciting Surge in Stock Value Tegna Inc. (NYSE: TGNA) is currently at the center of attention as its stock undergoes a remarkable surge, primarily driven by the potential acquisition by Nexstar Media Group Inc. (NASDAQ: NXST). The transaction, which is reportedly in advanced stages, could redefine the landscape of the media industry. The Significance of the...

Docusign's Upcoming Earnings Call: What Investors Should Know

Docusign Prepares for a Key Earnings Report Mark your calendars, because Docusign’s fiscal fourth quarter results are about to drop like a hot potato! On March 17, 2026, after the market closes, it’s showtime for shareholders looking to make sense of this company's latest financial stomping ground. If you thought Docusign was just about signatures, think again—this...

$BMSN News 10-Q: BIO-MATRIX SCIENTIFIC GROUP, INC. 7:10

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles